Bionik and Wistron to Develop Exoskeleton Technologies

Bionik Laboratories (OTCQX:BNKL) announced a joint development project with Wistron (TPE:3231) to design, engineer, and manufacture low-priced, lower-body assistive robotic technologies for mass commercial sale within the consumer home products market.
As quoted in the press release:

The companies plan to base the new consumer exoskeleton products off Bionik’s ARKE lower body exoskeleton, currently in clinical development for use within rehabilitation environments, as well as incorporating other important intellectual property relating to Bionik’s acquired or licensed assistive robotic technologies. The companies intend to target the Asian market initially, where the aging/elderly population is projected to hit 983 million by 2050, increasing the need for affordable assistive technologies over the next half century.
Wistron, which designs and manufactures technology products for global distribution with annual revenue exceeding $20 billion, will co-develop with Bionik a consumer exoskeleton product, which will be sold under the Bionik brand name and at a price point so they can be more widely available to the mass consumer market.
“Wistron is a highly significant organization within the manufacturing industry, so having an opportunity to combine our industry-leading expertise within the robotics industry with their product development resources is incredible for us,” said Peter Bloch, Chief Executive Officer of Bionik. “Our years of experience in medical robotics has provided us with strong clinical data and technology to help us access this growing market of robotics technologies in the area of human assistance. We intend to continue to seek out additional partnerships that will allow us to bring our technology to a mass audience within the consumer products sector.”

Click here to read the full press release.

Source: www.newswire.ca